In the presence of belatacept and lower MSC/effector cell ratios we even observed an additive suppressive effect.
MSC exert their immunomodulatory function not only by suppressing the proliferation of various immune cells; in a previous study we have shown that MSC also induce functional de-novo regulatory T cells (Treg) [63]. CD28/B7 co-stimulation in Treg is required for their differentiation [64]. Treg-specific deficiency of CD28 and CTLA-4 leads to an impaired immunosuppression by Treg and the development of autoimmunity and rejection in transplant models [65, 66]. The effect of CTLA-4-Ig therapy on Treg is controversial. Administration of CTLA-4-Ig to a skin transplant mouse model abolished Treg-dependent graft acceptance and expansion Selleckchem Pifithrin�� of Treg [67]. In contrast, CTLA-4-Ig therapy in rheumatoid arthritis this website patients reduced the frequency of peripheral Treg but enhanced their function [68]. Therefore, alongside the alloreactive CD8+CD28− T cells that escape belatacept therapy,
the possible diminution of Treg in patients receiving belatacept might contribute to the increased frequency of acute rejections reported for belatacept-treated kidney graft recipients [25]. In conclusion, CD8+CD28− T cells sustain their proliferative capacity in the presence of belatacept, and secrete cytolytic and cytotoxic effector molecules. As MSC are able to control these CD8+CD28− T cells by inhibiting their proliferation, our study suggests a potential for MSC–belatacept combination therapy to prevent alloreactivity after solid organ mTOR inhibitor transplantation. A. U. E. performed the experiments and participated in the writing of the manuscript. M. G. H. B. participated in
the writing of the manuscript. C. C. B, N. H. R. L., M. F., W. W. and M. J. H. participated in the study design and the writing of the manuscript. The authors of this manuscript have no financial or commercial conflicts of interest to disclose. “
“Natural killer T (NKT) cells are a heterogeneous population of lymphocytes that recognize antigens presented by CD1d and have attracted attention because of their potential role linking innate and adaptive immune responses. Peripheral NKT cells display a memory-activated phenotype and can rapidly secrete large amounts of pro-inflammatory cytokines upon antigenic activation. In this study, we evaluated NKT cells in the context of patients co-infected with HIV-1 and Mycobacterium leprae. The volunteers were enrolled into four groups: 22 healthy controls, 23 HIV-1-infected patients, 20 patients with leprosy and 17 patients with leprosy and HIV-1-infection. Flow cytometry and ELISPOT assays were performed on peripheral blood mononuclear cells. We demonstrated that patients co-infected with HIV-1 and M. leprae have significantly lower NKT cell frequencies [median 0.022%, interquartile range (IQR): 0.007–0.051] in the peripheral blood when compared with healthy subjects (median 0.077%, IQR: 0.032–0.405, P < 0.